When Success Rates Go Low, Cell-Based Screens Go High
To Boost Success Rates, Developers are Balancing High-Content and High-Throughput Screening
Top 10 European Biopharma Clusters
As Brexit Casts Uncertain Shadow, Continent’s Industry Continues Growth Trajectory
Non-Viral, Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
Goal Is the Development of Faster, More Affordable Therapies
Building the Ideal Bioprocessing Strategy
Searching for Innovative, Cost-Effective Product Options
For full access to this article login to GEN Select now.
Genomic Data in Patients’ Hands
- Strides in biotechnology and genomics have enabled individuals to gain access to increasingly more accurate and detailed information about their genomes at decreasing costs. While learning about individual genetic risks and susceptibilities has become more affordable, interpreting the data and establishing the optimal management strategies are opening challenges ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.